Acciones Peloton Therapeutics, Inc.
Acciones
PLTX
US70614L1044
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 01/11/17 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 01/01/11 |
David Chang
BRD | Director/Board Member | 64 | 01/02/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+18,15 % | 124 mil M | |
+18,02 % | 111 mil M | |
-12,75 % | 23,17 mil M | |
+5,07 % | 22,94 mil M | |
-39,94 % | 17,42 mil M | |
-9,86 % | 17,42 mil M | |
-14,97 % | 16,9 mil M | |
+2,80 % | 13,71 mil M | |
+27,39 % | 11,82 mil M |